These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 14744276)

  • 61. Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial.
    Wang TY; White JA; Tricoci P; Giugliano RP; Zeymer U; Harrington RA; Montalescot G; James SK; Van de Werf F; Armstrong PW; Braunwald E; Califf RM; Newby LK
    Circulation; 2011 Feb; 123(7):722-30. PubMed ID: 21300952
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A randomized trial assessing the impact of three different glycoprotein IIb/IIIa antagonists on glycoprotein IIb/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes.
    Holmes LE; Gupta R; Rajendran S; Luu J; French JK; Juergens CP
    Cardiovasc Ther; 2016 Oct; 34(5):330-6. PubMed ID: 27327862
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II.
    Lancet; 1997 May; 349(9063):1422-8. PubMed ID: 9164315
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Platelet receptor glycoprotein IIb/IIIa inhibition with eptifibatide in a patient with thrombocytopenia after treatment with abciximab.
    Coto H
    J Invasive Cardiol; 2000 Oct; 12(10):528-31. PubMed ID: 11022214
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Urgent carotid artery stenting with technical modifications for patients with transient ischemic attacks and minor stroke.
    Moratto R; Veronesi J; Silingardi R; Sacha NM; Trevisi Borsari G; Coppi G; Coppi G
    J Endovasc Ther; 2012 Oct; 19(5):627-35. PubMed ID: 23046328
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Postprocedure intravenous eptifibatide following intra-arterial reteplase in patients with acute ischemic stroke.
    Qureshi AI; Hussein HM; Janjua N; Harris-Lane P; Ezzeddine MA
    J Neuroimaging; 2008 Jan; 18(1):50-5. PubMed ID: 18190496
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
    Auer J; Berent R; Lassnig E; Weber T; Maurer E; Eber B
    Herz; 2003 Aug; 28(5):393-403. PubMed ID: 12928738
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Assessment of eptifibatide dosing in renal impairment before and after in-service education provided by pharmacists.
    Donovan JL; Schroeder WS; Tran MT; Foster K; Forrest A; Lee TB; Gandhi PJ
    J Manag Care Pharm; 2007 Sep; 13(7):598-606. PubMed ID: 17874866
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study.
    Burkart DJ; Borsa JJ; Anthony JP; Thurlo SR
    J Vasc Interv Radiol; 2003 Jun; 14(6):729-33. PubMed ID: 12817039
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study).
    Tcheng JE; Talley JD; O'Shea JC; Gilchrist IC; Kleiman NS; Grines CL; Davidson CJ; Lincoff AM; Califf RM; Jennings LK; Kitt MM; Lorenz TJ
    Am J Cardiol; 2001 Nov; 88(10):1097-102. PubMed ID: 11703951
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transcervical carotid stenting with internal carotid artery flow reversal: feasibility and preliminary results.
    Criado E; Doblas M; Fontcuberta J; Orgaz A; Flores A; Wall LP; Gasparis A; Lopez P; Strachan J; Ricotta J
    J Vasc Surg; 2004 Sep; 40(3):476-83. PubMed ID: 15337876
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy.
    Gibson CM; Cohen DJ; Cohen EA; Lui HK; Murphy SA; Marble SJ; Kitt M; Lorenz T; Tcheng JE
    Am J Cardiol; 2001 Jun; 87(11):1293-5. PubMed ID: 11377359
    [No Abstract]   [Full Text] [Related]  

  • 74. Intracarotid abciximab injection to abort impending ischemic stroke during carotid angioplasty.
    Ho DS; Wang Y; Chui M; Wang Y; Ho SL; Cheung RT
    Cerebrovasc Dis; 2001; 11(4):300-4. PubMed ID: 11385208
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prospective registry of carotid artery stenting in Japan--investigation on device and antiplatelet for carotid artery stenting.
    Sakai N; Yamagami H; Matsubara Y; Ezura M; Hyodo A; Matsumaru Y; Miyachi S; Okada Y; Terada T; Yokoi H; Nakamura M; Matsumoto Y; Sakai C;
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1374-84. PubMed ID: 24534127
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.
    EPIC Investigators
    N Engl J Med; 1994 Apr; 330(14):956-61. PubMed ID: 8121459
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Safety of "bridging" with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery.
    Rassi AN; Blackstone E; Militello MA; Theodos G; Cavender MA; Sun Z; Ellis SG; Cho L
    Am J Cardiol; 2012 Aug; 110(4):485-90. PubMed ID: 22591672
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation.
    Bertrand OF; De Larochellière R; Rodés-Cabau J; Proulx G; Gleeton O; Nguyen CM; Déry JP; Barbeau G; Noël B; Larose E; Poirier P; Roy L;
    Circulation; 2006 Dec; 114(24):2636-43. PubMed ID: 17145988
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Percutaneous internal carotid artery angioplasty with stenting: early and long-term results.
    Dabrowski M; Bielecki D; Gołebiewski P; Kwieciński H
    Kardiol Pol; 2003 Jun; 58(6):469-80. PubMed ID: 14556013
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Increased Rates of Hemorrhages after Endovascular Stroke Treatment with Emergency Carotid Artery Stenting and Dual Antiplatelet Therapy.
    Hadler F; Singh R; Wiesmann M; Reich A; Nikoubashman O
    Cerebrovasc Dis; 2021; 50(2):162-170. PubMed ID: 33472192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.